"Dream, Dream, Dream! Conduct these dreams into thoughts, and then transform them into action."
- Dr. A. P. J. Abdul Kalam
"Dream, Dream, Dream! Conduct these dreams into thoughts, and then transform them into action."
- Dr. A. P. J. Abdul Kalam
11 Jul 2023
A simple blood test that can detect ovarian cancer with a high degree of accuracy has been developed by a team of researchers from the University of Adelaide in Australia. The test uses three specific proteins to identify the presence of ovarian cancer in a patient's blood sample.
The proteins, known as HE4, CA125, and mesothelin, are already known to be associated with ovarian cancer. The researchers found that by combining these three proteins and analyzing them using a machine learning algorithm, they could accurately detect ovarian cancer in 90% of cases.
The test is non-invasive and can be conducted using a standard blood sample, making it a more convenient and accessible option for women who may be at risk of ovarian cancer. Additionally, the test is able to distinguish between different subtypes of ovarian cancer, which could help doctors to tailor treatment plans to individual patients.
Ovarian cancer is often difficult to detect in its early stages, as symptoms can be vague and easily missed. This new blood test could help to improve early detection rates and ultimately save lives.
The researchers are now working to further refine the test and conduct larger clinical trials to validate its effectiveness. If successful, this new blood test could become a valuable tool in the fight against ovarian cancer.
